<--- Back to Details
First PageDocument Content
Investment banks / Primary dealers / JPMorgan Chase / Dow Jones Industrial Average / Futures contract / Clearing house / J.P. Morgan & Co. / Futures exchange / J. P. Morgan / Investment / Financial economics / House of Morgan
Date: 2014-04-14 10:10:41
Investment banks
Primary dealers
JPMorgan Chase
Dow Jones Industrial Average
Futures contract
Clearing house
J.P. Morgan & Co.
Futures exchange
J. P. Morgan
Investment
Financial economics
House of Morgan

FRB Chicago OTC Derivatives Symposium Panel: CCP Loss Allocation and ‘End of Waterfall’ Scenarios Presented by: Marnie Rosenberg April 2014 CCP RECOVERY AND RESOLUTION

Add to Reading List

Source URL: chicagofed.org

Download Document from Source Website

File Size: 317,30 KB

Share Document on Facebook

Similar Documents

The future is here Project Ubin: SGD on Distributed Ledger A report developed with the contributions of Bank of America Merrill Lynch, BCS Information Systems, Credit Suisse, DBS Bank, HSBC, J.P. Morgan, Mitsubishi UFJ F

The future is here Project Ubin: SGD on Distributed Ledger A report developed with the contributions of Bank of America Merrill Lynch, BCS Information Systems, Credit Suisse, DBS Bank, HSBC, J.P. Morgan, Mitsubishi UFJ F

DocID: 1xUJj - View Document

J. Pierpont MorganJ.P. Morgan & Co 23 Wall Street -Financed

J. Pierpont MorganJ.P. Morgan & Co 23 Wall Street -Financed

DocID: 1v6UG - View Document

Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco Cambridge, UK, 2 January 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell enga

Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco Cambridge, UK, 2 January 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell enga

DocID: 1v0OC - View Document

Visterra to Present at the 32nd Annual J.P. Morgan Healthcare Conference - CEO Brian Pereira to Provide Update on Therapeutic Pipeline for Infectious Diseases Developed Using Proprietary Hierotope™ Platform - Company L

Visterra to Present at the 32nd Annual J.P. Morgan Healthcare Conference - CEO Brian Pereira to Provide Update on Therapeutic Pipeline for Infectious Diseases Developed Using Proprietary Hierotope™ Platform - Company L

DocID: 1uNNM - View Document

Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis M. Brett, M. R. Persey, M. M. Reilly, T. Revesz, D. R. Booth, S. E. Booth, P. N. Hawkins, M. B. Pepys and J. A. Morgan-Hughes

Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis M. Brett, M. R. Persey, M. M. Reilly, T. Revesz, D. R. Booth, S. E. Booth, P. N. Hawkins, M. B. Pepys and J. A. Morgan-Hughes

DocID: 1uD9w - View Document